BFA
AMAG

BlackRock Fund Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Fund Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$120M Buy
3,437,673
+273,278
+9% +$8.16M 0.02% 1063
2016
Q3 		$77.6M Buy
3,164,395
+163,791
+5% +$4.09M 0.02% 1274
2016
Q2 		$71.8M Buy
3,000,604
+70,170
+2% +$1.61M 0.02% 1250
2016
Q1 		$68.6M Buy
2,930,434
+1,529,853
+109% +$36.3M 0.02% 1239
2015
Q4 		$42.3M Buy
1,400,581
+435,075
+45% +$14.1M 0.01% 1586
2015
Q3 		$38.4M Sell
965,506
-5,655
-0.6% -$351K 0.01% 1591
2015
Q2 		$67.1M Sell
971,161
-42,931
-4% -$2.7M 0.02% 1311
2015
Q1 		$55.4M Sell
1,014,092
-7,790
-0.8% -$371K 0.01% 1440
2014
Q4 		$43.6M Sell
1,021,882
-25,851
-2% -$934K 0.01% 1550
2014
Q3 		$33.4M Sell
1,047,733
-44,090
-4% -$940K 0.01% 1627
2014
Q2 		$22.6M Buy
1,091,823
+87,839
+9% +$1.62M 0.01% 1948
2014
Q1 		$19.4M Sell
1,003,984
-1,583
-0.2% -$33.6K 0.01% 2010
2013
Q4 		$24.4M Buy
1,005,567
+24,266
+2% +$571K 0.01% 1874
2013
Q3 		$21.1M Buy
981,301
+80,832
+9% +$1.91M 0.01% 1934
2013
Q2 		$20M Buy
+900,469
New +$19.8M 0.01% 1856

Other funds holding AMAG

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Fund Advisors's AMAG Position: Q4 2016 in Review

BlackRock Fund Advisors increased its AMAG Pharmaceuticals (AMAG) stake by 8.6% in Q4 2016, buying an estimated $8.16M and bringing the position to 3,437,673 shares worth $120M. The position accounts for 0.02% of the portfolio, ranked #1063.

BlackRock Fund Advisors first reported a position in AMAG in Q2 2013 and has held it in 15 quarters since. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • BlackRock Fund Advisors held 3,437,673 shares of AMAG Pharmaceuticals worth $120M as of Q4 2016.
  • BlackRock Fund Advisors bought 273,278 AMAG Pharmaceuticals shares in Q4 2016, an estimated $8.16M.
  • AMAG Pharmaceuticals made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1063 holding.
  • BlackRock Fund Advisors first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.